Suwon, South Korea

Hang-Bum Jo

This inventor holds 1 USPTO granted patent. Top assignee: Yuhan Corporation. Active years: 2001.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hang-Bum Jo. Retrieved from https://idiyas.com/inventor/hang-bum-jo

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2001

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Hang-Bum Jo

Introduction

Hang-Bum Jo is a notable inventor based in Suwon, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of capsule compositions. His work focuses on enhancing the effectiveness and release profiles of medications.

Latest Patents

Hang-Bum Jo holds a patent for a pharmaceutical capsule composition containing loratadine and pseudoephedrine. This innovative composition is designed for oral administration and exhibits controllable, satisfactory release profiles of both active ingredients. The patent details a formulation that includes rapid-release pellets containing loratadine and pseudoephedrine, as well as extended-release pellets coated with a water-insoluble polymer and a wet-blocking agent.

Career Highlights

Hang-Bum Jo is associated with Yuhan Corporation, a leading pharmaceutical company in South Korea. His work at Yuhan Corporation has been instrumental in advancing pharmaceutical formulations and improving patient outcomes through innovative drug delivery systems.

Collaborations

He has collaborated with notable colleagues such as Young-Joon Park and Hyun-Soo Kim, contributing to the collective expertise and innovation within their projects.

Conclusion

Hang-Bum Jo's contributions to pharmaceutical innovations highlight the importance of research and development in improving medication efficacy. His patent for a novel capsule composition exemplifies the potential for advancements in drug delivery systems.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…